Kim Innes

Patients

Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry.

News

New data at WCLC26 could push GSK's ROS1+ NSCLC drug Jideytro into the first-line setting, while B7-H3-targeted ADC ris-rez extends survival in SCLC.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.